Reply to thread

Message: <blockquote data-quote="imhotep" data-source="post: 29729249" data-attributes="member: 562115">I don't think it's costed as yet.  Propionic Acidemia (PA) Is a Rare Inherited Metabolic Disorder. Primarily paediatric neonatal disease.Global prevalence is less than 5 in 100,000 newborns.mRNA-3927 is a novel, IV-administered, lipid nanoparticle (LNP)- encapsulated dual mRNA therapy that encodes for PCCA and PCCB subunit proteins to restore functional PCC enzyme activity in the liver.Currently 10 doses.Drug companies invest hugely in developing these and the final pricing depends on the development costs and sales forecasts. Moderna stocks jumped after the announcement.PS: The cost you are referring is probaly not the answer. <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite18" alt=":ROFLMAO:" title="ROFL    :ROFLMAO:" loading="lazy" data-shortname=":ROFLMAO:" /></blockquote>

Top Bottom